Thrombopoietic compounds
US8541201B2 · kind B2 · utility
9Cited by
31References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 2011 |
| Grant date | Sep 24, 2013 |
| Priority date | — |
| Expiry date | Jul 19, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.